瓦博格效应
癌细胞
糖酵解
PI3K/AKT/mTOR通路
厌氧糖酵解
癌症
癌症研究
生物
肿瘤微环境
代谢途径
新陈代谢
细胞生物学
生物化学
信号转导
肿瘤细胞
遗传学
作者
Ali F. Abdel-Wahab,Waheed Mahmoud,Randa M. Al-Harizy
标识
DOI:10.1016/j.phrs.2019.104511
摘要
Most solid tumor cells adapt to their heterogeneous microenvironment by depending largely on aerobic glycolysis for energy production, a phenomenon called the Warburg effect, which is a hallmark of cancer. The altered energy metabolism not only provides cancer cell with ATP for cellular energy, but also generate essential metabolic intermediates that play a pivotal role in the biosynthesis of macromolecules, to support cell proliferation, invasiveness, and chemoresistance. The cellular metabolic reprogramming in cancer is regulated by several oncogenic proteins and tumor suppressors such as hypoxia-inducible factor (HIF-1), Myc, p53, and PI3K/Akt/mTOR pathway. A better understanding of the mechanisms involved in the regulation of aerobic glycolysis can help in developing glycolytic inhibitors as anticancer agents. These metabolic antiglycolytic agents could be more effective if used in drug combinations to combat cancer. Several preclinical and early clinical studies have shown the effectiveness of targeting the glycolytic pathway as a therapeutic approach to suppress cancer progression. This review aimed to present the most recent data on the emerging drug candidate targeting enzymes and intermediates involved in glucose metabolism to provide therapeutic opportunities and challenges for antiglycolytic cancer therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI